VAPOTHERM INC

2024 Q3 Form 10-Q Financial Statement

#000095017024095540 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.904M
YoY Change -83.87%
Cash & Equivalents $2.904M
Short-Term Investments
Other Short-Term Assets $2.259M
YoY Change -50.0%
Inventory $23.30M
Prepaid Expenses
Receivables $8.563M
Other Receivables $0.00
Total Short-Term Assets $37.02M
YoY Change -34.57%
LONG-TERM ASSETS
Property, Plant & Equipment $23.59M
YoY Change -3.49%
Goodwill $561.0K
YoY Change -0.18%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.677M
YoY Change 3.44%
Total Long-Term Assets $30.91M
YoY Change -7.75%
TOTAL ASSETS
Total Short-Term Assets $37.02M
Total Long-Term Assets $30.91M
Total Assets $67.93M
YoY Change -24.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.381M
YoY Change 102.82%
Accrued Expenses $22.91M
YoY Change 96.49%
Deferred Revenue $177.0K
YoY Change 43.9%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $118.4M
YoY Change
Total Short-Term Liabilities $147.0M
YoY Change 871.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.288M
YoY Change -69.89%
Total Long-Term Liabilities $2.288M
YoY Change -69.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.0M
Total Long-Term Liabilities $2.288M
Total Liabilities $149.2M
YoY Change 19.84%
SHAREHOLDERS EQUITY
Retained Earnings -$577.3M
YoY Change 10.41%
Common Stock $496.1M
YoY Change 1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$81.32M
YoY Change
Total Liabilities & Shareholders Equity $67.93M
YoY Change -24.6%

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000
dei Entity Central Index Key
EntityCentralIndexKey
0001253176
dei Amendment Flag
AmendmentFlag
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
NH
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38740
dei Entity Registrant Name
EntityRegistrantName
Vapotherm, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2259298
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Domain Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Exeter
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
03833
dei City Area Code
CityAreaCode
603
dei Local Phone Number
LocalPhoneNumber
658-0011
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6244935
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2904000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9725000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
240000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8563000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10672000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23295000
CY2023Q4 us-gaap Inventory Net
InventoryNet
22968000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8563000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10672000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23295000
CY2023Q4 us-gaap Inventory Net
InventoryNet
22968000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2259000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3058000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
37021000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2259000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3058000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
37021000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
46423000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23592000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23703000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2911000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3372000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
46423000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23592000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23703000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2911000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3372000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
56000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
57000
CY2024Q2 us-gaap Goodwill
Goodwill
561000
CY2023Q4 us-gaap Goodwill
Goodwill
565000
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
56000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
57000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2677000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2388000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2677000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2388000
CY2024Q2 us-gaap Assets
Assets
67927000
CY2023Q4 us-gaap Assets
Assets
77617000
CY2024Q2 us-gaap Assets
Assets
67927000
CY2023Q4 us-gaap Assets
Assets
77617000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4381000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5053000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1258000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12805000
CY2024Q2 us-gaap Loans Payable Current
LoansPayableCurrent
118406000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
146958000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4381000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5053000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1258000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1237000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22913000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12805000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
146958000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19095000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19095000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
107059000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
107059000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2288000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6797000
CY2023Q4 us-gaap Liabilities
Liabilities
132951000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2288000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6797000
CY2024Q2 us-gaap Liabilities
Liabilities
149246000
CY2023Q4 us-gaap Liabilities
Liabilities
132951000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21875000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21875000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21875000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21875000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6241958
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6241958
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6165806
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6165806
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
496083000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
492764000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-106000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
91000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-577302000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-548195000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-81319000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-55334000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67927000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77617000
CY2024Q2 us-gaap Revenues
Revenues
16884000
CY2023Q2 us-gaap Revenues
Revenues
16037000
us-gaap Revenues
Revenues
36018000
us-gaap Revenues
Revenues
33768000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
8601000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
9177000
us-gaap Cost Of Revenue
CostOfRevenue
18078000
us-gaap Cost Of Revenue
CostOfRevenue
20696000
CY2024Q2 us-gaap Gross Profit
GrossProfit
8283000
CY2023Q2 us-gaap Gross Profit
GrossProfit
6860000
us-gaap Gross Profit
GrossProfit
17940000
us-gaap Gross Profit
GrossProfit
13072000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3328000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3723000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6960000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7710000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6732000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8276000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13874000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17868000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3768000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5019000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8240000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10789000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3723000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3723000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
432000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6241958
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6241958
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6165806
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6165806
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
496083000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
492764000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-106000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
91000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-577302000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-548195000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-81319000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-55334000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67927000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77617000
CY2024Q2 us-gaap Revenues
Revenues
16884000
CY2023Q2 us-gaap Revenues
Revenues
16037000
us-gaap Revenues
Revenues
36018000
us-gaap Revenues
Revenues
33768000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
8601000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
9177000
us-gaap Cost Of Revenue
CostOfRevenue
18078000
us-gaap Cost Of Revenue
CostOfRevenue
20696000
CY2024Q2 us-gaap Gross Profit
GrossProfit
8283000
CY2023Q2 us-gaap Gross Profit
GrossProfit
6860000
us-gaap Gross Profit
GrossProfit
17940000
us-gaap Gross Profit
GrossProfit
13072000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3328000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3723000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6960000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7710000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6732000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8276000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13874000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17868000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3768000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5019000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8240000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10789000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3723000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3723000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
432000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-53000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6328222
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6328222
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6436631
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6436631
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5705607
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5705607
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-55334000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
16000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1814000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-53000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
17550000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
17016000
us-gaap Operating Expenses
OperatingExpenses
32788000
us-gaap Operating Expenses
OperatingExpenses
36852000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9267000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10156000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14848000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23780000
CY2024Q2 us-gaap Interest Expense
InterestExpense
4944000
CY2023Q2 us-gaap Interest Expense
InterestExpense
4642000
us-gaap Interest Expense
InterestExpense
14197000
us-gaap Interest Expense
InterestExpense
8973000
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
26000
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-43000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-39000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-145000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14253000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14763000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29078000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32844000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-14271000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14788000
us-gaap Net Income Loss
NetIncomeLoss
-29107000
us-gaap Net Income Loss
NetIncomeLoss
-32878000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-35000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-197000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
113000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-35000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-22000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-197000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
113000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14306000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14810000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29304000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32765000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
17550000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
17016000
us-gaap Operating Expenses
OperatingExpenses
32788000
us-gaap Operating Expenses
OperatingExpenses
36852000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9267000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10156000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14848000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23780000
CY2024Q2 us-gaap Interest Expense
InterestExpense
4944000
CY2023Q2 us-gaap Interest Expense
InterestExpense
4642000
us-gaap Interest Expense
InterestExpense
14197000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
26000
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000
us-gaap Investment Income Interest
InvestmentIncomeInterest
54000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-43000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-39000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-145000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14253000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14763000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29078000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32844000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-14271000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14788000
us-gaap Net Income Loss
NetIncomeLoss
-32878000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-35000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-197000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
113000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-35000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-22000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
113000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14306000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32765000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.22
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.34
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.76
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6442763
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6442763
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-162000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-14836000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-68481000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12000
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
135000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1321000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-14271000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-81319000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28190000
CY2023Q1 vapo Issuance Of Common Stock And Pre Funded Warrants And Accompanying Warrants In Private Placements Net
IssuanceOfCommonStockAndPreFundedWarrantsAndAccompanyingWarrantsInPrivatePlacementsNet
20943000
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
59000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
28000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2761000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
135000
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.22
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.34
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.76
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6442763
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6442763
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6328222
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6328222
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6436631
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6436631
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5705607
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5705607
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-55334000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
16000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1814000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-162000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-14836000
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12000
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
135000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1321000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-14271000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-81319000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-28190000
CY2023Q1 vapo Issuance Of Common Stock And Pre Funded Warrants And Accompanying Warrants In Private Placements Net
IssuanceOfCommonStockAndPreFundedWarrantsAndAccompanyingWarrantsInPrivatePlacementsNet
20943000
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
59000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
28000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2761000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
135000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18090000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-18090000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-22354000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-22354000
CY2023Q2 vapo Issuance Of Common Stock Upon Exercise Of Pre Funded Warrants
IssuanceOfCommonStockUponExerciseOfPreFundedWarrants
3000
CY2023Q2 vapo Issuance Of Common Stock Upon Exercise Of Pre Funded Warrants
IssuanceOfCommonStockUponExerciseOfPreFundedWarrants
3000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
77000
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
58000
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
58000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
43000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
43000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2527000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2527000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14788000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-34456000
us-gaap Profit Loss
ProfitLoss
-29107000
us-gaap Profit Loss
ProfitLoss
-32878000
us-gaap Share Based Compensation
ShareBasedCompensation
3290000
us-gaap Share Based Compensation
ShareBasedCompensation
5405000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2528000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2445000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
110000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-2000
vapo Provision For Inventory Valuation
ProvisionForInventoryValuation
-73000
vapo Provision For Inventory Valuation
ProvisionForInventoryValuation
-283000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
461000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
733000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
432000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-53000
vapo Placed Units Reserve
PlacedUnitsReserve
234000
vapo Placed Units Reserve
PlacedUnitsReserve
418000
us-gaap Paid In Kind Interest
PaidInKindInterest
4918000
us-gaap Paid In Kind Interest
PaidInKindInterest
4553000
vapo Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-4931000
vapo Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-620000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
429000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
368000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
29000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
34000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1986000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-212000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
407000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7646000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-506000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2794000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-579000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-315000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
23000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
72000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2045000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3460000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1288000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2662000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1408000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2662000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1408000
vapo Proceeds From Issuance Of Common Stock And Pre Funded Warrants Andaccompanying Warrants In Private Placement Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsAndaccompanyingWarrantsInPrivatePlacementNetOfIssuanceCosts
20943000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5820000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14788000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-34456000
us-gaap Profit Loss
ProfitLoss
-29107000
us-gaap Profit Loss
ProfitLoss
-32878000
us-gaap Share Based Compensation
ShareBasedCompensation
3290000
us-gaap Share Based Compensation
ShareBasedCompensation
5405000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2528000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2445000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
110000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-2000
vapo Provision For Inventory Valuation
ProvisionForInventoryValuation
-73000
vapo Provision For Inventory Valuation
ProvisionForInventoryValuation
-283000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
461000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
733000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
432000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
9000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-53000
vapo Placed Units Reserve
PlacedUnitsReserve
234000
vapo Placed Units Reserve
PlacedUnitsReserve
418000
us-gaap Paid In Kind Interest
PaidInKindInterest
4918000
us-gaap Paid In Kind Interest
PaidInKindInterest
4553000
vapo Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-4931000
vapo Non Cash Interest Income Expense
NonCashInterestIncomeExpense
-620000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
429000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
368000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
29000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
34000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1986000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-212000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
407000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7646000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-506000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2794000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-579000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-315000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
23000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
72000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2045000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3460000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1288000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1213000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9827000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17388000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2662000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1408000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2662000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1408000
vapo Proceeds From Issuance Of Common Stock And Pre Funded Warrants Andaccompanying Warrants In Private Placement Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsAndaccompanyingWarrantsInPrivatePlacementNetOfIssuanceCosts
20943000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5820000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5833000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-165000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6821000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2262000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10834000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16847000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4013000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19109000
us-gaap Interest Paid Net
InterestPaidNet
3557000
us-gaap Interest Paid Net
InterestPaidNet
2720000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
732000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
175000
vapo Issuance Of Common Stock Warrants In Conjunction With Long Term Debt
IssuanceOfCommonStockWarrantsInConjunctionWithLongTermDebt
16000
vapo Issuance Of Common Stock Warrants In Conjunction With Long Term Debt
IssuanceOfCommonStockWarrantsInConjunctionWithLongTermDebt
71000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
155000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
117000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000
CY2024Q2 vapo Working Capital
WorkingCapital
-109900000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-577300000
us-gaap Net Income Loss
NetIncomeLoss
-29100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9800000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5833000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21023000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-165000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6821000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2262000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10834000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16847000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4013000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19109000
us-gaap Interest Paid Net
InterestPaidNet
3557000
us-gaap Interest Paid Net
InterestPaidNet
2720000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
732000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
175000
vapo Issuance Of Common Stock Warrants In Conjunction With Long Term Debt
IssuanceOfCommonStockWarrantsInConjunctionWithLongTermDebt
16000
vapo Issuance Of Common Stock Warrants In Conjunction With Long Term Debt
IssuanceOfCommonStockWarrantsInConjunctionWithLongTermDebt
71000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
155000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
117000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000
CY2024Q2 vapo Working Capital
WorkingCapital
-109900000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-577300000
us-gaap Net Income Loss
NetIncomeLoss
-29100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9800000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:7.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, realizability of inventories, allowance for credit losses, accrued expenses, the valuation allowances against deferred income tax assets, and assessments of impairment with respect to long-lived and intangible assets, including goodwill. Actual results may differ from these estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:7.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts in 2023 have been reclassified to conform to the presentation in 2024. None of the reclassifications had any impact on the Company’s results of operations.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:7.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, realizability of inventories, allowance for credit losses, accrued expenses, the valuation allowances against deferred income tax assets, and assessments of impairment with respect to long-lived and intangible assets, including goodwill. Actual results may differ from these estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:7.92%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts in 2023 have been reclassified to conform to the presentation in 2024. None of the reclassifications had any impact on the Company’s results of operations.</span></p>
vapo Cash And Cash Equivalents Maturity Date Description
CashAndCashEquivalentsMaturityDateDescription
90 days
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10800000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9725000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10834000
vapo Standard Product Warranty Period
StandardProductWarrantyPeriod
P1Y
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
303000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-30000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
108000
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
165000
vapo Cash And Cash Equivalents Maturity Date Description
CashAndCashEquivalentsMaturityDateDescription
90 days
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10800000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2904000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9725000
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1109000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4013000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10834000
vapo Standard Product Warranty Period
StandardProductWarrantyPeriod
P1Y
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
303000
us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-30000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
108000
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
165000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
vapo Standard Payment Terms To Customer
StandardPaymentTermsToCustomer
P30D
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying a practical expedient under ASC 606, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less.
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3700000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3700000
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
vapo Standard Payment Terms To Customer
StandardPaymentTermsToCustomer
P30D
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying a practical expedient under ASC 606, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less.
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 vapo Fair Value Assets Transfers In And Out Of Level12 Or3
FairValueAssetsTransfersInAndOutOfLevel12Or3
0
CY2024Q2 vapo Fair Value Assets Transfers In And Out Of Level12 Or3
FairValueAssetsTransfersInAndOutOfLevel12Or3
0
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8803000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10832000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
240000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8563000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10672000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
160000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
110000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
240000
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8803000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10832000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
160000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8563000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10672000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
160000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
110000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
240000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11982000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10722000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9954000
CY2024Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
614000
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
1032000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23295000
CY2023Q4 us-gaap Inventory Net
InventoryNet
22968000
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11959000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11982000
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10722000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9954000
CY2024Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
614000
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
1032000
CY2024Q2 us-gaap Inventory Net
InventoryNet
23295000
CY2023Q4 us-gaap Inventory Net
InventoryNet
22968000
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000
us-gaap Inventory Write Down
InventoryWriteDown
100000
us-gaap Inventory Write Down
InventoryWriteDown
300000
CY2024Q2 vapo Accrued Term Loan Fees Current
AccruedTermLoanFeesCurrent
9079000
CY2024Q2 vapo Accrued Merger Costs
AccruedMergerCosts
3018000
CY2024Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2030000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1927000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1958000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2414000
CY2024Q2 vapo Accrued Income Sales And Other Taxes Current
AccruedIncomeSalesAndOtherTaxesCurrent
912000
CY2023Q4 vapo Accrued Income Sales And Other Taxes Current
AccruedIncomeSalesAndOtherTaxesCurrent
997000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
781000
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
667000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
847000
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
530000
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
548000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
522000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
617000
CY2024Q2 vapo Accrued Inventories Current
AccruedInventoriesCurrent
503000
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000
us-gaap Inventory Write Down
InventoryWriteDown
100000
us-gaap Inventory Write Down
InventoryWriteDown
300000
CY2024Q2 vapo Accrued Term Loan Fees Current
AccruedTermLoanFeesCurrent
9079000
CY2024Q2 vapo Accrued Merger Costs
AccruedMergerCosts
3018000
CY2024Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2030000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1927000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1958000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2414000
CY2024Q2 vapo Accrued Income Sales And Other Taxes Current
AccruedIncomeSalesAndOtherTaxesCurrent
912000
CY2023Q4 vapo Accrued Income Sales And Other Taxes Current
AccruedIncomeSalesAndOtherTaxesCurrent
997000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
781000
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
667000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
847000
CY2024Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
530000
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
548000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
522000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
617000
CY2024Q2 vapo Accrued Inventories Current
AccruedInventoriesCurrent
503000
CY2023Q4 vapo Accrued Inventories Current
AccruedInventoriesCurrent
596000
CY2024Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
459000
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
494000
CY2024Q2 vapo Accrued Supplier Costs Current
AccruedSupplierCostsCurrent
450000
CY2023Q4 vapo Accrued Supplier Costs Current
AccruedSupplierCostsCurrent
450000
CY2024Q2 vapo Accrued Freight Current
AccruedFreightCurrent
252000
CY2023Q4 vapo Accrued Freight Current
AccruedFreightCurrent
243000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
165000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
303000
CY2023Q4 vapo Accrued Rent And Restoration Costs Current
AccruedRentAndRestorationCostsCurrent
489000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1693000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2099000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22913000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2919000
CY2023Q4 vapo Accrued Term Loan Fees Noncurrent
AccruedTermLoanFeesNoncurrent
3874000
CY2024Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3000
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
4000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2288000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6797000
CY2024Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
459000
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
494000
CY2024Q2 vapo Accrued Supplier Costs Current
AccruedSupplierCostsCurrent
450000
CY2023Q4 vapo Accrued Supplier Costs Current
AccruedSupplierCostsCurrent
450000
CY2024Q2 vapo Accrued Freight Current
AccruedFreightCurrent
252000
CY2023Q4 vapo Accrued Freight Current
AccruedFreightCurrent
243000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
165000
CY2023Q4 vapo Accrued Rent And Restoration Costs Current
AccruedRentAndRestorationCostsCurrent
489000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1693000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2099000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22913000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12805000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2285000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2919000
CY2023Q4 vapo Accrued Term Loan Fees Noncurrent
AccruedTermLoanFeesNoncurrent
3874000
CY2024Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3000
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
4000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2288000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6797000
us-gaap Operating Lease Cost
OperatingLeaseCost
1075000
us-gaap Operating Lease Cost
OperatingLeaseCost
1075000
us-gaap Operating Lease Cost
OperatingLeaseCost
1075000
us-gaap Operating Lease Cost
OperatingLeaseCost
1075000
us-gaap Variable Lease Cost
VariableLeaseCost
198000
us-gaap Variable Lease Cost
VariableLeaseCost
193000
us-gaap Lease Cost
LeaseCost
1273000
us-gaap Lease Cost
LeaseCost
1268000
us-gaap Operating Lease Payments
OperatingLeasePayments
1802000
us-gaap Operating Lease Payments
OperatingLeasePayments
1556000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.104
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
811000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
525000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
481000
CY2024Q2 vapo Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
655000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5141000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
898000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4243000
CY2024Q2 us-gaap Guaranty Liabilities
GuarantyLiabilities
1300000
CY2024Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
11243000
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
3163000
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
14406000
us-gaap Variable Lease Cost
VariableLeaseCost
198000
us-gaap Variable Lease Cost
VariableLeaseCost
193000
us-gaap Lease Cost
LeaseCost
1273000
us-gaap Lease Cost
LeaseCost
1268000
us-gaap Operating Lease Payments
OperatingLeasePayments
1802000
us-gaap Operating Lease Payments
OperatingLeasePayments
1556000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.104
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1492000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1177000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
811000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
525000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
481000
CY2024Q2 vapo Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
655000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5141000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
898000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4243000
CY2024Q2 us-gaap Guaranty Liabilities
GuarantyLiabilities
1300000
CY2024Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
11243000
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
3163000
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
14406000
us-gaap Restructuring And Related Cost Description
RestructuringAndRelatedCostDescription
There were no restructuring expenses recorded during the three or six months ended June 30, 2024 or six months ended June 30, 2023. All amounts related to the April 2022 and the August 2022 Restructuring were fully paid in 2023.
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring And Related Cost Description
RestructuringAndRelatedCostDescription
There were no restructuring expenses recorded during the three or six months ended June 30, 2024 or six months ended June 30, 2023. All amounts related to the April 2022 and the August 2022 Restructuring were fully paid in 2023.
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Restructuring Charges
RestructuringCharges
0
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
488000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16884000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36018000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16037000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33768000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1041000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
196000
vapo Increase In Deferred Revenue Current
IncreaseInDeferredRevenueCurrent
725000
vapo Decrease In Contract With Customer Liability Current
DecreaseInContractWithCustomerLiabilityCurrent
196000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1081000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
177000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
488000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16037000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33768000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1041000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
196000
vapo Increase In Deferred Revenue Current
IncreaseInDeferredRevenueCurrent
725000
vapo Increase In Contract With Customer Liability Current
IncreaseInContractWithCustomerLiabilityCurrent
177000
vapo Decrease In Deferred Revenue Current
DecreaseInDeferredRevenueCurrent
685000
vapo Decrease In Contract With Customer Liability Current
DecreaseInContractWithCustomerLiabilityCurrent
196000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1081000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
177000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1456000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2585000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3290000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5405000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
106071
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.68
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.038
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2024Q2 vapo Performance Stock Units Percentage Minimum
PerformanceStockUnitsPercentageMinimum
0
CY2024Q2 vapo Performance Stock Units Percentage Maximum
PerformanceStockUnitsPercentageMaximum
2
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1456000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2585000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3290000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5405000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
106071
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.68
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.038
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2024Q2 vapo Performance Stock Units Percentage Minimum
PerformanceStockUnitsPercentageMinimum
0
CY2024Q2 vapo Performance Stock Units Percentage Maximum
PerformanceStockUnitsPercentageMaximum
2
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4168993
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3463963
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-095540-index-headers.html Edgar Link pending
0000950170-24-095540-index.html Edgar Link pending
0000950170-24-095540.txt Edgar Link pending
0000950170-24-095540-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vapo-20240630.htm Edgar Link pending
vapo-20240630.xsd Edgar Link pending
vapo-ex31_1.htm Edgar Link pending
vapo-ex31_2.htm Edgar Link pending
vapo-ex32_1.htm Edgar Link pending
vapo-ex32_2.htm Edgar Link pending
vapo-20240630_htm.xml Edgar Link completed